Literature DB >> 27358773

Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Ashley Mehl1, Humberto Bohorquez1, Maria-Stella Serrano1, Gretchen Galliano1, Trevor W Reichman1.   

Abstract

Progressive familial intrahepatic cholestasis (PFIC) is a constellation of inherited disorders that result in the impairment of bile flow through the liver that predominantly affects children. The accumulation of bile results in progressive liver damage, and if left untreated leads to end stage liver disease and death. Patients often present with worsening jaundice and pruritis within the first few years of life. Many of these patients will progress to end stage liver disease and require liver transplantation. The role and timing of liver transplantation still remains debated especially in the management of PFIC1. In those patients who are appropriately selected, liver transplantation offers an excellent survival benefit. Appropriate timing and selection of patients for liver transplantation will be discussed, and the short and long term management of patients post liver transplantation will also be described.

Entities:  

Keywords:  Bile salt excretion protein; Cholestasis; Familial intrahepatic cholestasis protein 1; Multidrug resistance protein 3; Pediatric jaundice; Pediatric liver transplant; Progressive familial intrahepatic cholestasis

Year:  2016        PMID: 27358773      PMCID: PMC4919732          DOI: 10.5500/wjt.v6.i2.278

Source DB:  PubMed          Journal:  World J Transplant        ISSN: 2220-3230


  91 in total

1.  An outstanding non-transplant surgical intervention in progressive familial intrahepatic cholestasis: partial internal biliary diversion.

Authors:  F Gün; B Erginel; O Durmaz; S Sökücü; T Salman; A Celik
Journal:  Pediatr Surg Int       Date:  2010-06-20       Impact factor: 1.827

2.  Biliary diversion by use of the appendix (cholecystoappendicostomy) in progressive familial intrahepatic cholestasis.

Authors:  W Rebhandl; F X Felberbauer; J Turnbull; K Paya; U Barcik; W D Huber; P F Whitington; E Horcher
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-02       Impact factor: 2.839

3.  Two Case Reports of Successful Treatment of Cholestasis With Steroids in Patients With PFIC-2.

Authors:  Guido Engelmann; Daniel Wenning; Diran Herebian; Oliver Sander; Carola Dröge; Stefanie Kluge; Ralf Kubitz
Journal:  Pediatrics       Date:  2015-04-06       Impact factor: 7.124

4.  Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.

Authors:  P L Jansen; S S Strautnieks; E Jacquemin; M Hadchouel; E M Sokal; G J Hooiveld; J H Koning; A De Jager-Krikken; F Kuipers; F Stellaard; C M Bijleveld; A Gouw; H Van Goor; R J Thompson; M Müller
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

Review 5.  FIC1 disease: a spectrum of intrahepatic cholestatic disorders.

Authors:  S W van Mil; L W Klomp; L N Bull; R H Houwen
Journal:  Semin Liver Dis       Date:  2001-11       Impact factor: 6.115

6.  Therapeutic interventions in progressive familial intrahepatic cholestasis: experience from a tertiary care centre in north India.

Authors:  Satvinder Kaur; Deepa Sharma; Nishant Wadhwa; Subash Gupta; Sujit Kumar Chowdhary; Anupam Sibal
Journal:  Indian J Pediatr       Date:  2011-07-19       Impact factor: 1.967

7.  De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.

Authors:  Verena Keitel; Martin Burdelski; Zsuzsanna Vojnisek; Lutz Schmitt; Dieter Häussinger; Ralf Kubitz
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

8.  Preoperative observations and short-term outcome after partial external biliary diversion in 13 patients with progressive familial intrahepatic cholestasis.

Authors:  Henrik Arnell; Sven Bergdahl; Nikos Papadogiannakis; Antal Nemeth; Björn Fischler
Journal:  J Pediatr Surg       Date:  2008-07       Impact factor: 2.545

9.  Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation.

Authors:  Panayotis Lykavieris; Saskia van Mil; Danièle Cresteil; Monique Fabre; Michelle Hadchouel; Leo Klomp; Olivier Bernard; Emmanuel Jacquemin
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

10.  Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass.

Authors:  P J Kaliciński; H Ismail; I Jankowska; A Kamiński; J Pawłowska; T Drewniak; M Markiewicz; M Szymczak
Journal:  Eur J Pediatr Surg       Date:  2003-10       Impact factor: 2.191

View more
  17 in total

1.  A New Variant of an Old Itch: Novel Missense Variant in ABCB4 Presenting with Intractable Pruritus.

Authors:  Sahana Shankar; Apurva Pande; Thenral S Geetha; Karthik Raichurkar; Malikarjun Sakpal; Rajiv Lochan; Sonal Asthana
Journal:  J Clin Exp Hepatol       Date:  2021-04-29

2.  Progressive Familial Intrahepatic Cholestasis: A Study in Children From a Liver Transplant Center in India.

Authors:  Sagar Mehta; Karunesh Kumar; Ravi Bhardwaj; Smita Malhotra; Neerav Goyal; Anupam Sibal
Journal:  J Clin Exp Hepatol       Date:  2021-06-13

3.  Total Internal Biliary Diversion for Post-Liver Transplant PFIC-1-Related Allograft Injury.

Authors:  Naresh Shanmugam; Jagadeesh Menon; Mukul Vij; Ashwin Rammohan; Rajesh Rajalingam; Mohamed Rela
Journal:  J Clin Exp Hepatol       Date:  2021-03-30

4.  Odevixibat and partial external biliary diversion showed equal improvement of cholestasis in a patient with progressive familial intrahepatic cholestasis.

Authors:  Christoph Slavetinsky; Ekkehard Sturm
Journal:  BMJ Case Rep       Date:  2020-06-29

Review 5.  Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.

Authors:  You-Wen Tan; Hai-Lei Ji; Zhong-Hua Lu; Guo-Hong Ge; Li Sun; Xin-Bei Zhou; Jian-Hui Sheng; Yu-Hua Gong
Journal:  World J Gastroenterol       Date:  2018-11-07       Impact factor: 5.742

6.  Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models.

Authors:  Virginie Vauthier; Amel Ben Saad; Jonathan Elie; Nassima Oumata; Anne-Marie Durand-Schneider; Alix Bruneau; Jean-Louis Delaunay; Chantal Housset; Tounsia Aït-Slimane; Laurent Meijer; Thomas Falguières
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

Review 7.  Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis.

Authors:  Binita M Kamath; Philip Stein; Roderick H J Houwen; Henkjan J Verkade
Journal:  Liver Int       Date:  2020-06-22       Impact factor: 5.828

8.  Clinical spectrum of chronic liver disease with final outcome in children at a tertiary centre: A single - centre study.

Authors:  Iqtadar Seerat; Eitzaz Ud Din Khan; Muhammad Atique; Usman Iqbal Aujla
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

9.  Balancing Medical and Non-Accidental Causes of Multiple Fractures in a Child with Progressive Familial Intrahepatic Cholestasis.

Authors:  Hisham Abdelrhim; Sami Khan; Paul Heaton; Rajeev Peeka
Journal:  Am J Case Rep       Date:  2017-11-09

10.  Liver Transplantation for Progressive Familial Intrahepatic Cholestasis.

Authors:  Ying Liu; Li-Ying Sun; Zhi-Jun Zhu; Lin Wei; Wei Qu; Zhi-Gui Zeng
Journal:  Ann Transplant       Date:  2018-09-25       Impact factor: 1.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.